2 research outputs found
Additional file 1: Table S1. of The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry
Patient characteristics for the overall group with those receiving an ACE inhibitor other than ramipril being excluded (n = 151) and split by RCT eligibility at baseline and availability of the 12-month follow-up. (DOC 53 kb
Additional file 1: Table S1. of Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry
Blood pressure values achieved at 6 and 12 months respectively (DOCX 28 kb